Brief: Shield Therapeutics Says FY Total Revenue And Other Income Of $17.5 Mln
Feb 21 (Reuters) - Shield Therapeutics PLC STXS.L :
* SHIELD THERAPEUTICS - UNAUDITED FULL YEAR TRADING UPDATE
* SHIELD THERAPEUTICS PLC - FULL YEAR 2023 TOTAL REVENUE AND
OTHER
INCOME OF $17.5M COMPARED TO $6.2M IN 2022
* SHIELD THERAPEUTICS PLC - FULL YEAR 2023 ACCRUFER® REVENUE
OF
$11.6M, APPROXIMATELY THREE TIMES MORE THAN PRIOR YEAR
Source text for Eikon: ID:nRSU8985Da
Further company coverage: STXS.L
(Reuters.Briefs@thomsonreuters.com)
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update